Mineralocorticoid receptor antagonists mitigate mitral regurgitation-induced myocardial dysfunction

HIGHLIGHTS

  • who: Wei-Ting Chang et al. from the Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan have published the article: Mineralocorticoid Receptor Antagonists Mitigate Mitral Regurgitation-Induced Myocardial Dysfunction, in the Journal: Cells 2022, 11, x FOR PEER REVIEW of /2022/
  • what: The authors investigate the efficacy of spironolactone in improving cardiac remodeling in MR-induced HF compared with that of a loop diuretic furosemide.
  • how: In the study both clinical observation and a novel mini-invasive rat model of degenerative MR were used to investigate the efficacy . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?